Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 10, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

向进化灵感的骨髓瘤治疗方向建模表型异质性

Darcy L Welch1,2, Brooke L Fridley3, Ling Cen3

  • 1Adolescent and Young Adult Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Scientific reports
|November 18, 2023
PubMed
概括

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hematopoietic mosaic chromosomal alterations are pleiotropic drivers of inflammaging, multimorbidity, and mortality.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

JCO oncology practice·2026
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Adaptive and sequential cancer therapies emerge from treatment schedule optimization.

Research square·2026
Same author

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Cancer research·2026
Same author

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026

在骨髓瘤 (骨癌) 中,内异质性会影响化疗的有效性. 这项研究模拟异质性,揭示环境变化和顺序疗法如何克服患者的治疗耐药性.

科学领域:

  • 在瘤学瘤学.
  • 癌症生物学 癌症生物学
  • 生物技术是生物技术.

背景情况:

  • 骨髓瘤是儿科和年轻成年人群中最常见的骨癌.
  • 化疗耐药性,通常是由内异质性驱动的,约有一半局部骨髓瘤病例的治疗疗效受到限制.
  • 了解细胞异质性对于开发更有效的治疗策略至关重要.

研究的目的:

  • 开发和描述基于表型和基因型变异的骨髓瘤异质性的体外模型.
  • 研究环境和化学干扰如何影响共同培养的骨髓瘤细胞系的行为.
  • 在异质骨髓瘤模型中评估克服化疗抵抗的治疗策略.

主要方法:

  • 骨髓瘤细胞系面板的基因型和表型特征,重点关注不同细胞系的共同培养 (143B和SAOS2).
  • 在不同的环境条件下 (如pH,谷氨酸水平) 和化疗暴露下评估细胞系竞争.
  • 评估球状体的形成和对单剂和连续化疗治疗的反应,在两细胞线共同培养模型中.

主要成果:

  • 环境因素 (pH,谷氨胺) 和化疗显著改变了共同培养的骨髓瘤细胞系的组成和成功.
  • 在营养丰富的条件下,143B细胞超过了SAOS2细胞,但在营养缺乏或接受化疗的球状体中观察到SAOS2的优势.
  • 序列化疗,从第一冲击剂转换为第二冲击剂,是唯一有效消除异质球体的评估方法.

更多相关视频

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

833
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.3K

相关实验视频

Last Updated: Jul 10, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

833
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.3K

结论:

  • 开发的体外模型有效地回顾了骨髓瘤异质性及其对治疗反应的影响.
  • 异质种群中的环境条件和细胞相互作用极大地影响治疗结果.
  • 顺序治疗策略对于克服骨髓瘤内异质性介导的化学抵抗是必不可少的.